# Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia

> **NCT05797623** · PHASE2 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 78 (estimated)

## Conditions studied

- Non-severe Aplastic Anemia

## Interventions

- **DRUG:** Trappa ethanolamine tablets ; ciclosporin
- **DRUG:** Placebo ; ciclosporin

## Key facts

- **NCT ID:** NCT05797623
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-26
- **Primary completion:** 2024-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2023-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05797623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05797623, "Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Treatment of Non-severe Aplastic Anemia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05797623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*